Add to ORKGBorbély AN. Conjugates of Cryptophycin and RGD Peptides for Targeted Cancer Therapy. Bielefeld: Universität Bielefeld; 2019
In recent years, targeted therapies have raised increasing interest as effective strategies to impro...
Sewald N. Peptide-drug conjugates for tumor targeting. In: Journal of Peptide Science . Vol 28. Hob...
Borbély AN, Figueras Agustí E, Martins A, et al. Conjugates of Cryptophycin and RGD or isoDGR Peptid...
Borbély AN, Figueras Agustí E, Martins A, et al. Novel Cryptophycin-based Conjugates for Tumor Targe...
Cryptophycins are potent tubulin polymerization inhibitors with picomolar antiproliferative potency ...
Figueras Agustí E, Martins A, Borbély AN, et al. Tumor Targeting of Cryptophycin based Conjugates Us...
Nahrwold M, Weiß C, Bogner T, et al. Conjugates of modified cryptophycins and RGD-peptides enter tar...
Borbély AN, Figueras Agustí E, Martins A, et al. Synthesis and Biological Evaluation of RGD–Cryptoph...
Figueras Agustí E. Novel cryptophycin analogues and conjugates for tumor targeted therapy . Bielefel...
Borbély AN, Thoreau F, Figueras Agustí E, et al. Synthesis and Biological Characterization of Monome...
We review drug conjugates combining a tumor-selective moiety with a cytotoxic agent as cancer treatm...
Drug conjugates have become a significant focus of research in the field of targeted medicine for ca...
Conjugation of cytotoxic agents to targeting carriers (e.g. antibodies or small molecules) capable o...
Glioblastoma (GBM) is the most aggressive tumor type in the central nervous system. Both tumor targe...
Tumor targeting anticancer drug conjugates that contain a tumor recognition motif (homing device) ar...
In recent years, targeted therapies have raised increasing interest as effective strategies to impro...
Sewald N. Peptide-drug conjugates for tumor targeting. In: Journal of Peptide Science . Vol 28. Hob...
Borbély AN, Figueras Agustí E, Martins A, et al. Conjugates of Cryptophycin and RGD or isoDGR Peptid...
Borbély AN, Figueras Agustí E, Martins A, et al. Novel Cryptophycin-based Conjugates for Tumor Targe...
Cryptophycins are potent tubulin polymerization inhibitors with picomolar antiproliferative potency ...
Figueras Agustí E, Martins A, Borbély AN, et al. Tumor Targeting of Cryptophycin based Conjugates Us...
Nahrwold M, Weiß C, Bogner T, et al. Conjugates of modified cryptophycins and RGD-peptides enter tar...
Borbély AN, Figueras Agustí E, Martins A, et al. Synthesis and Biological Evaluation of RGD–Cryptoph...
Figueras Agustí E. Novel cryptophycin analogues and conjugates for tumor targeted therapy . Bielefel...
Borbély AN, Thoreau F, Figueras Agustí E, et al. Synthesis and Biological Characterization of Monome...
We review drug conjugates combining a tumor-selective moiety with a cytotoxic agent as cancer treatm...
Drug conjugates have become a significant focus of research in the field of targeted medicine for ca...
Conjugation of cytotoxic agents to targeting carriers (e.g. antibodies or small molecules) capable o...
Glioblastoma (GBM) is the most aggressive tumor type in the central nervous system. Both tumor targe...
Tumor targeting anticancer drug conjugates that contain a tumor recognition motif (homing device) ar...
In recent years, targeted therapies have raised increasing interest as effective strategies to impro...
Sewald N. Peptide-drug conjugates for tumor targeting. In: Journal of Peptide Science . Vol 28. Hob...
Borbély AN, Figueras Agustí E, Martins A, et al. Conjugates of Cryptophycin and RGD or isoDGR Peptid...